All News Concord Drugs Limited

Equities

CONCORD6

INE858L01010

Market Closed - Bombay S.E. Other stock markets 11:00:54 31/05/2024 BST			5-day change	1st Jan Change
37.03 ^INR	-2.37%		-5.92%	-37.99%

03-19	Concord Drugs Limited Announces Appointment of Namratha Nagla as Company Secretary/Compliance Officer	CI
02-13	Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Concord Drugs Limited Announces Appointment of Namratha Nagla as Company Secretary/Compliance Officer	03-19	CI
Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Concord Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Concord Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	30/05/23	CI
Concord Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	30/05/23	CI
Concord Drugs Eyes INR 207 Million Rights Issue	14/04/23	MT
Concord Drugs Limited Announces Resignation of AnkurBisht, Company Secretary and Compliance Officer	08/04/23	CI
Concord Drugs Limited acquired 100% stake in Proton Remedies Private Limited for INR 14.2 million.	22/03/23	CI
Concord Drugs Limited Appoints Mr. Ankur Bisht as Company Secretary and Compliance Officer, Effective on February 16, 2023	14/02/23	CI
Concord Drugs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23	CI
Concord Drugs Limited Announces Resignation of Rakshit Sethiya as Company Secretary and Compliance Officer	11/11/22	CI
Concord Drugs Limited announced that it has received INR 10.364063 million in funding	06/11/22	CI
Concord Drugs Limited Appoints RakshitSethiya as Company Secretary and Compliance Officer	04/11/22	CI
Concord Drugs Limited announced that it expects to receive INR 10.364063 million in funding	06/09/22	CI
Concord Drugs Limited agreed to acquire 100% stake in Proton Remedies Private Limited.	06/09/22	CI
Concord Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22	CI
Concord Drugs Limited Announces Director Changes	02/06/22	CI
Concord Drugs Limited Announces Resignation of Jyoti Goyal as Company Secretary and Compliance Officer	06/05/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Concord Drugs Limited

Equities

CONCORD6

INE858L01010

All News

Filters